Advertisement

Journal of General Internal Medicine

, Volume 23, Issue 11, pp 1757–1762 | Cite as

Prevalence and Risk Factors for Depressive Symptoms in Persons with Chronic Obstructive Pulmonary Disease

  • Rebecca E. Schane
  • Prescott G. Woodruff
  • Alexis Dinno
  • Ken E. Covinsky
  • Louise C. Walter
Article

Abstract

Background

Although depression is a risk factor for adverse outcomes in chronic illness, little is known about the prevalence or risk factors for depressive symptoms in chronic obstructive pulmonary disease (COPD).

Objective

To determine the prevalence of depressive symptoms in COPD as compared to other chronic illnesses and to identify risk factors for depressive symptoms in COPD.

Design and Patients

Cross-sectional study of 18,588 persons (1,736 subjects with self-reported COPD), representing a sample of the US population aged ≥50 years who participated in the 2004 Health and Retirement Survey.

Measurements

Presence of COPD and other chronic conditions was defined by self-report. Presence of depressive symptoms was assessed using the CES-D8 scale. Participants with a score ≥3 on CES-D8 were classified as having clinically significant depressive symptoms.

Main Results

Of 1,736 participants with COPD, 40% had ≥3 depressive symptoms. Depressive symptoms were more common in COPD than in coronary heart disease, stroke, diabetes, arthritis, hypertension, and cancer. Risk factors for ≥3 depressive symptoms in COPD: younger age (OR 1.02/per year younger, 95% CI [1.02–1.03]), female gender (1.2 [1.1–1.3]), current smoking (1.5 [1.3–1.7]), marital status [divorced/separated (1.8 [1.6–2.1]), widowed (1.8 [1.6–2]), never married (1.4 [1.1–1.8]), ≤high school degree (1.6 [1.5–1.8]), dyspnea (2.3 [2.1–2.6]), difficulty walking (2.8 [2.5–3.2]), and co-morbid diabetes (1.2 [1.1–1.4]), arthritis (1.3 [1.2–1.5]) or cancer (1.2 [1.1–1.4]).

Conclusions

Depressive symptoms are common in COPD and are more likely to occur in COPD than in other common chronic illnesses. The risk factors identified may be used for targeted depression screening in COPD patients.

KEY WORDS

chronic obstructive pulmonary disease (COPD) depressive symptoms risk factors 

Notes

Acknowledgements

The Institute for Social Research at the University of Michigan collects HRS data that is principally funded by the National Institutes on Aging.

Dr. Schane is a recipient of an NIH Training Grant T32 HL007185.

Dr. Woodruff is a recipient of an NIH Training Grant HL074431.

Dr. Covinsky is a recipient of a grant from the National Institute on Aging (R01AG023626).

Dr. Dinno is a recipient of an NIH Training Grant 1 R25 CA113710-02.

Dr. Walter is a recipient of the Veteran’s Affairs Advanced Research Career Development Award in Health Services Research and Development and a Robert Wood Johnson Physician Faculty Scholar.

Conflict of Interest

The funding sources had no role in the design and conduct of the study, or in the collection, management, analysis, and interpretation of the data or in the preparation, review, or approval of the manuscript. Dr. Schane had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr. Dinno performed the statistical analysis for this study. The views expressed in this article are those of the authors and do not necessarily reflect the position or the policy of the University of California.

References

  1. 1.
    Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):121S–6S, May.PubMedCrossRefGoogle Scholar
  2. 2.
    Report TWH. Mental Health: New Understanding, New Hope. Geneva, Switzerland: World Health Organization 2001.Google Scholar
  3. 3.
    World Health Organization. Burden of COPD. http://www.who.int/respiratory/copd/burden/en/. Accessed July 9, 2008.
  4. 4.
    Borson S, Claypoole K, McDonald GJ. Depression and chronic obstructive pulmonary disease: treatment trials. Semin Clin Neuropsychiatry. 1998;3(2):115–30, Apr.PubMedGoogle Scholar
  5. 5.
    Cully JA, Graham DP, Stanley MA, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006;47(4):312–9, Jul–Aug.PubMedCrossRefGoogle Scholar
  6. 6.
    Gift AG, McCrone SH. Depression in patients with COPD. Heart Lung. 1993;22(4):289–97, Jul–Aug.PubMedGoogle Scholar
  7. 7.
    Whooley MA, Browner WS. Association between depressive symptoms and mortality in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1998;158(19):2129–35, Oct 26.PubMedCrossRefGoogle Scholar
  8. 8.
    Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–67, Jan 8.PubMedCrossRefGoogle Scholar
  9. 9.
    Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–9, Sep.PubMedCrossRefGoogle Scholar
  10. 10.
    McCathie HC, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J. 2002;19(1):47–53, Jan.PubMedCrossRefGoogle Scholar
  11. 11.
    Stein MB, Cox BJ, Afifi TO, Belik SL, Sareen J. Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med. 2006;36(5):587–96, May.PubMedCrossRefGoogle Scholar
  12. 12.
    Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5):491–6, Sep.PubMedCrossRefGoogle Scholar
  13. 13.
    Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology. 2006;11(2):188–95, Mar.PubMedCrossRefGoogle Scholar
  14. 14.
    Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12(2):113–7, Mar.PubMedCrossRefGoogle Scholar
  15. 15.
    van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54(8):688–92, Aug.PubMedCrossRefGoogle Scholar
  16. 16.
    Wong SY, Woo J, Lynn HS, Leung J, Tang YN, Leung PC. Risk of depression in patients with chronic respiratory diseases: results from two large cohort studies in Chinese elderly from Hong Kong. Int J Geriatr Psychiatry. 2006;21(3):233–8, Mar.PubMedCrossRefGoogle Scholar
  17. 17.
    Crockett AJ, Cranston JM, Moss JR, Alpers JH. The impact of anxiety, depression and living alone in chronic obstructive pulmonary disease. Qual Life Res. 2002;11(4):309–16, Jun.PubMedCrossRefGoogle Scholar
  18. 18.
    Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med. 2006;100(10):1767–74, Oct.PubMedCrossRefGoogle Scholar
  19. 19.
    van Manen JG, Bindels PJ, Dekker FW, Ijzermans CJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57(5):412–6, May.PubMedCrossRefGoogle Scholar
  20. 20.
    Radloff L. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRefGoogle Scholar
  21. 21.
    Steffick DE, Wallace RB, Herzog AR, Ofstedal MB, Fonda S, Langa K. Documentation of Affective Functioning Measures in the Health and Retirement Survey. Ann Arbor: University of Michigan; 2000.Google Scholar
  22. 22.
    Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84, Mar–Apr.PubMedGoogle Scholar
  23. 23.
    Blazer D, Burchett B, Service C, George LK. The association of age and depression among the elderly: an epidemiologic exploration. J Gerontol. 1991;46(6):M210–15, Nov.PubMedGoogle Scholar
  24. 24.
    Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79(11):1554–6, Nov.PubMedCrossRefGoogle Scholar
  25. 25.
    Simpson CF, Boyd CM, Carlson MC, Griswold ME, Guralnik JM, Fried LP. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc. 2004;52(1):123–7, Jan.PubMedCrossRefGoogle Scholar
  26. 26.
    Rubin D. Multiple Imputation After 18+ Years. J Am Stat Assoc. 1996;91(434):473–89.CrossRefGoogle Scholar
  27. 27.
    Schafer J. Multiple imputation: a primer. Stat Methods Med Res. 1999;8(1):3–15.PubMedCrossRefGoogle Scholar
  28. 28.
    Royson P. Multiple Imputation of missing values. Stata J. 2004;4(3):227–41.Google Scholar
  29. 29.
    Royson P. Multiple Imputation of missing values: update. Stata J. 2005;5(2):118–201.Google Scholar
  30. 30.
    Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. Ser B (Methodological). 1995;57(1):289–300.Google Scholar
  31. 31.
    de Jonge P, Ormel J, van den Brink RH, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry. 2006;163(1):138–44. Jan.PubMedCrossRefGoogle Scholar
  32. 32.
    Skotzko CE. Symptom perception in CHF: (why mind matters). Heart Fail Rev. Dec 11 2007.Google Scholar
  33. 33.
    Rabe KF, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med. 2007;175(12):1222–32. Jun 15.PubMedCrossRefGoogle Scholar
  34. 34.
    Tashkin DP, Cooper CB. The role of long-acting bronchodilators in the management of stable COPD. Chest. 2004;125(1):249–59, Jan.PubMedCrossRefGoogle Scholar
  35. 35.
    Kelly HW. Risk versus benefit considerations for the beta(2)-agonists. Pharmacotherapy. 2006;26(9 Pt 2):164S–74S, Sep.PubMedCrossRefGoogle Scholar
  36. 36.
    Walters JA, Walters EH, Woodbaker R. Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005(3):CD005374.Google Scholar
  37. 37.
    DeBellis RJ. Mechanism of action of long- acting bronchodilators. Clin Pulmon Med. 2005;12(Supplement 1):S10–S12, July.CrossRefGoogle Scholar
  38. 38.
    Cullen DL. Long term oxygen therapy adherence and COPD: what we don’ know. Chron Respir Dis. 2006;3(4):217–22.PubMedCrossRefGoogle Scholar
  39. 39.
    Wilhelm K, Arnold K, Niven H, Richmond R. Grey lungs and blue moods: smoking cessation in the context of lifetime depression history. Aust N Z J Psychiatry. 2004;38(11–12):896–905, Nov–Dec.PubMedCrossRefGoogle Scholar
  40. 40.
    Glassman AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry. 1993;150(4):546–53, Apr.PubMedGoogle Scholar
  41. 41.
    Barr RG, Herbstman J, Speizer FE, Camargo CA Jr. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 2002;155(10):965–71, May 15.PubMedCrossRefGoogle Scholar
  42. 42.
    Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971–2000. MMWR Surveill Summ. 2002;51(6):1–16, Aug 2.Google Scholar
  43. 43.
    Pirraglia PA, Charbonneau A, Kader B, Berlowitz DR. Adequate initial antidepressant treatment among patients with chronic obstructive pulmonary disease in a cohort of depressed veterans. Prim Care Companion J Clin Psychiatry. 2006;8(2):71–6.PubMedGoogle Scholar
  44. 44.
    Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2001;16(5):451–54, May.PubMedCrossRefGoogle Scholar
  45. 45.
    Eiser N, West C, Evans S, Jeffers A, Quirk F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J. 1997;10(7):1581–4, Jul.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2008

Authors and Affiliations

  • Rebecca E. Schane
    • 1
    • 3
  • Prescott G. Woodruff
    • 1
  • Alexis Dinno
    • 3
  • Ken E. Covinsky
    • 2
  • Louise C. Walter
    • 2
  1. 1.Department of Medicine, Division of Pulmonary-Critical Care Medicine, the Cardiovascular Research InstituteUniversity of CaliforniaSan FranciscoUSA
  2. 2.Department of Medicine, Division of Geriatrics, San Francisco VA Medical CenterUniversity of CaliforniaSan FranciscoUSA
  3. 3.Department of Medicine, Center for Tobacco Control Research and Education, the Cardiovascular Research InstituteUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations